March

HealthXL Monthly Report

2015

(scroll down)

HealthXL Monthly Report, March 2015

www.healthxl.org 2

Welcome to the HealthXL Report for March 2015. Every month we get the opportunity to talk to a wide range of innovative digital health companies. This report profiles a subset of these companies that we have interviewed and see as the most exciting, because of their market traction, innovative technology and new creative models for the delivery of care.

All companies featured in this report relate to the HealthXL Moonshots and Challenges. For the purpose of this report, a brief of each of the HealthXL Moonshots and Challenges is provided below.

HealthXL Moonshots Big Data Moonshot Accessing, integrating and applying disparate and new sources of data that has clinical relevance to the caregiver. Improving health literacy and provide actionable data that incentivizes the patient to engage and improve their own healthcare.

Connected Health Moonshot Providing synchronous and seamless monitoring from conception to end of life regardless of the time, place, person or device.

Behavior Change Moonshot Millions of hearts beating younger, stronger and longer by informing consumers with more reasons to be healthy, and engaging the support of peers, family, friends and work colleagues in each others well being.

HealthXL Challenges Heart Failure Challenge To reduce avoidable hospital readmissions for heart failure patients through the utilization of connected devices selected to suit the individual patients needs, combined with behavioral modification and therapeutic interventions. This will enable better post discharge monitoring of the patient and early intervention if exasperation is detected using home care teams.

COPD Challenge Build a COPD patient monitoring system utilizing the most effective connected health devices to feed a predictive algorithm capable of early detection of patient health deterioration. A predictive algorithm that is both sensitive and specific enough to recognize the early onset of a hospitalization event should enable sufficient time to treat the patient prior to the need to hospitalize thereby increasing the QOL of the patient and reducing the number of “revolving door” COPD patients admitted to hospitals.

Clinical Trials Challenge The model and costs for developing new drugs is unsustainable, currently costing $2.5b over a 10-year period. The aim of this Challenge is to examine all aspects of the clinical trials process and identify areas that could be improved through the use of emerging innovations.

HealthXL Monthly Report, March 2015

www.healthxl.org 3

Towerview Health help the 1 in 3 Americans with a chronic illness manage multiple medications. TowerView’s patients receive pre-filled medication trays that fit into a connected pillbox like a K-Cup into a Keurig coffee machine. Their pillbox can sense when patients forget a dose and automatically send a text message or phone call reminder.

Country: USA Website: www.towerviewhealth.com

Moonshot: Connected Health Challenge: Heart Failure

Towerview Health

HealthXL Monthly Report, March 2015

www.healthxl.org 4

The CareMessage platform and associated disease management programs enable healthcare organizations to facilitate communication and outreach with 'smart' SMS and voice technology, particularly focused on chronic and behavioral health diseases. Intimately tied to intelligent technology, CareMessage has also created highly engaging disease management content designed to help patients with diabetes, hypertension, CHF, COPD, pregnancy, asthma, substance abuse, depression etc.

Country: USA Website: www.caremessage.org

Moonshot: Behavior Change Challenge: Clinical Trials, COPD, Heart Failure

CareMessage

HealthXL Monthly Report, March 2015

www.healthxl.org 5

Neumitra develops embedded biomodules to accurately and continuously measure the autonomic nervous system throughout daily life demands. The company uses mobile software to link contextual data, such as events, locations, and activities, with the physiology of stress toward self-managing symptoms and identifying their causes.

Country: USA Website: www.neumitra.com

Moonshot: Behavior Change Challenge: Clinical Trials, COPD, Heart Failure

Neumitra

HealthXL Monthly Report, March 2015

www.healthxl.org 6

Kurbo is a digital health company that has developed a mobile-based weight management program for kids and families. The program has two parts; a fun and engaging app to help young people eat healthier and lose weight, and remote coaching to provide accountability, support and feedback. The Kurbo program is licensed from the Packard Weight Control Program at Stanford.

Country: USA Website: www.kurbo.com

Moonshot: Behavior Change Challenge: N/A

Kurbo Health

HealthXL Monthly Report, March 2015

www.healthxl.org 7

Validic’s one to many API connects payers, providers, healthcare IT organizations, wellness organizations, and pharmaceutical organizations to the ever-expanding ecosystem of mobile health applications and devices. Validic’s API connects into their customers portal, platform, or web-based end-user engagement area and allows the member or health manager to connect over 140 health and wellness devices. The data from those devices is then delivered for use, display, and analysis.

Country: USA Website: www.validic.com

Moonshot: Connected Health Challenge: Clinical Trials, COPD, Heart Failure

Validic

HealthXL Monthly Report, March 2015

www.healthxl.org 8

Newtopia is a personalized health engagement platform that leverages genetic testing and the latest behavioral science to inspire at-risk individuals to make the right lifestyle decisions to live healthier lives. Newtopia is partnering with insurers, employers and brands to offer disease prevention and management programs to risk-assessed individuals that deliver proven sustainable outcomes, quantifiable cost savings and a substantial ROI.

Country: USA Website: www.newtopia.com

Moonshot: Behavior Change Challenge: N/A

Newtopia

HealthXL Monthly Report, March 2015

www.healthxl.org 9

Diameter Health improves healthcare quality and efficiency through clinical intelligence. Diameter Health offers targeted and cost effective analytic solutions to health providers so they can forecast patient outcomes, avoid penalties and provide insight for clinical documentation.

Country: USA Website: www.diameterhealth.com

Moonshot: Big Data Challenge: COPD, Heart Failure

Diameter Health

HealthXL Monthly Report, March 2015

www.healthxl.org 10

Case managers lack effective tools to maintain relationships with the flood of chronic patients. Welkin Health addresses this problem by providing a platform for building long-term relationships with patients across various communication channels, allowing case managers to focus on people rather than software.

Country: USA Website: www.welkinhealth.com

Moonshot: Connected Health Challenge: N/A

Welkin Health

HealthXL Monthly Report, March 2015

www.healthxl.org 11

CliniOps enables complete digitalization of clinical trials, through comprehensive and global solutions for eSourcing, Monitoring and Patient Engagement. CliniOps leverages technology in clinical trials, to improve quality, increase efficiency, reduce cycle time and bring down cost.

Country: USA Website: www.cliniops.com

Moonshot: Connected Health Challenge: Clinical Trials

CliniOps

HealthXL Monthly Report, March 2015

www.healthxl.org 12

With the transition to value/outcomes based reimbursements, innovative health providers need a scalable manner to provide chronic and post acute care. Healarium’s platform helps provider organizations drive revenue by enabling physicians to prescribe and manage evidence based care plans for patient adherence.

Country: USA/Israel Website: www.healarium.com

Moonshot: Behavior Change Challenge: COPD, Heart Failure

Healarium

HealthXL Monthly Report, March 2015

www.healthxl.org 13

Neurotrack is developing a highly accurate predictive tool based on behavioral biomarkers that has the potential to transform the way Alzheimer's disease is diagnosed and treated. A computer-based cognitive test, Neurotrack's technology can identify individuals at risk of conversion towards Alzheimer's disease 3-6 years before symptoms appear, helping to enable more cost effective and well powered clinical trials and eventually serving as an annual screening test for Alzheimer’s.

Country: USA Website: www.neurotrack.com

Moonshot: Connected Health Challenge: Clinical Trials

Neurotrack

want to receive the

next HealthXL Monthly Report?

What digital health leaders say :

Contact us